October 31, 2017
12:00pm-1:30pm ET

Listeria monocytogenes bacteria sickens an estimated 1,600 people each year and of those about 260 die. The dangers of Listeria foodborne illness impacting U.S. consumers are very real and the implications of an outbreak can be enormously costly to the food processing industry.

FDA is currently reviewing public comments to

The Department of Health and Human Services’ Office of Inspector General (OIG) issued a report last week detailing the results of its review the Food and Drug Administration’s (FDA’s) inspection of domestic food facilities, as well as its advisory and enforcement actions taken in response to significant inspection violations. The key takeaway from the report

The Food and Drug Administration (FDA) has issued a proposed rule to extend the compliance date for the final rules revising the requirements for the Nutrition and Supplement Facts Labels and the declared serving sizes and reference amounts customarily consumed (RACCs). Under the proposed rule, the compliance date would be extended by about 18 months

The U.S. Court of Appeals for the Eighth Circuit has affirmed prison sentences for two senior food company executives as “responsible corporate officers” for the sale of adulterated shell eggs to the public.  The decision reinforces the prevailing view that a “responsible corporate officer” at a food company can face criminal liability even without a

FSIS has released a brief Q&A addressing issues related to the new requirement that establishments report to their district offices all instances of adulterated or misbranded products within 24 hours of learning or determining that products have entered commerce. The reporting requirement applies for products received by or originating from an establishment. 9 C.F.R. §

The Food Safety and Inspection Service (FSIS) will publish in an upcoming issue of the Federal Register a final rule requiring official establishments to notify the agency of adulterated or misbranded food in commerce, creating significant reporting obligations. The final rule also requires establishments to maintain written recall plans and document in writing the results

The Food and Drug Administration has recently revised portions of Section 6 of its Regulatory Procedures Manual, which, among other things, outlines internal agency procedures regarding Park Doctrine prosecutions. After years of dormancy, these procedures reflect the agency’s renewed interest in using the longstanding Park doctrine as part of its enforcement regime. After providing some